X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (660) 660
Publication (66) 66
Newsletter (20) 20
Newspaper Article (13) 13
Book Review (10) 10
Book Chapter (4) 4
Data Set (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (460) 460
rifabutin (384) 384
male (261) 261
female (245) 245
pharmacology & pharmacy (197) 197
adult (194) 194
index medicus (170) 170
rifabutin - administration & dosage (166) 166
animals (155) 155
middle aged (149) 149
drug therapy, combination (140) 140
tuberculosis (140) 140
rifabutin - therapeutic use (129) 129
microbiology (110) 110
infectious diseases (108) 108
drug interactions (106) 106
rifabutin - analogs & derivatives (100) 100
rifampin (99) 99
mice (98) 98
pharmacokinetics (93) 93
clarithromycin (92) 92
lactams, macrocyclic (88) 88
benzoquinones (87) 87
mycobacterium avium-intracellulare infection - drug therapy (83) 83
anti-bacterial agents - administration & dosage (81) 81
anti-bacterial agents - therapeutic use (81) 81
rifabutin - pharmacology (81) 81
infection (75) 75
rifampicin (73) 73
treatment outcome (72) 72
tuberculosis - drug therapy (72) 72
rifabutin - adverse effects (70) 70
antitubercular agents - administration & dosage (69) 69
drug therapy (67) 67
rifabutin - pharmacokinetics (67) 67
clarithromycin - administration & dosage (63) 63
drug administration schedule (63) 63
aids (61) 61
aids-related opportunistic infections - drug therapy (60) 60
hiv (59) 59
quinones - pharmacology (58) 58
helicobacter pylori (57) 57
dose-response relationship, drug (55) 55
immunology (54) 54
rifampin - administration & dosage (54) 54
aged (53) 53
antibiotics, antitubercular - administration & dosage (52) 52
antitubercular agents - therapeutic use (52) 52
clarithromycin - therapeutic use (51) 51
gastroenterology & hepatology (51) 51
hiv infections - drug therapy (50) 50
dosage and administration (49) 49
health aspects (49) 49
care and treatment (46) 46
helicobacter infections - drug therapy (46) 46
microbial sensitivity tests (46) 46
respiratory system (46) 46
rifapentine (46) 46
ethambutol (45) 45
mycobacterium avium complex (45) 45
therapy (44) 44
antibiotics, antitubercular - therapeutic use (43) 43
human-immunodeficiency-virus (43) 43
infections (42) 42
rats (41) 41
research (40) 40
hiv infections - complications (39) 39
rifampin - pharmacology (39) 39
tuberculosis, pulmonary - drug therapy (39) 39
anti-bacterial agents - adverse effects (38) 38
mycobacterium tuberculosis - drug effects (38) 38
oncology (38) 38
rifampin - therapeutic use (38) 38
mycobacterium avium-intracellulare infection - prevention & control (37) 37
mycobacterium-tuberculosis (36) 36
prospective studies (36) 36
time factors (36) 36
anti-bacterial agents - pharmacology (35) 35
disease (35) 35
adolescent (33) 33
antibacterial agents (33) 33
antitubercular agents - pharmacokinetics (33) 33
prophylaxis (32) 32
pulmonary tuberculosis (32) 32
retrospective studies (32) 32
antibiotics (31) 31
enzyme inhibitors - pharmacology (31) 31
helicobacter pylori - drug effects (31) 31
levofloxacin (31) 31
research article (31) 31
rifampin - analogs & derivatives (31) 31
rifampin - pharmacokinetics (31) 31
antibiotics, antitubercular - adverse effects (30) 30
antibiotics, antitubercular - pharmacokinetics (30) 30
ethambutol - administration & dosage (30) 30
administration, oral (29) 29
treatment failure (29) 29
area under curve (28) 28
mycobacterium avium complex - drug effects (28) 28
protein-tyrosine kinases - antagonists & inhibitors (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (661) 661
French (8) 8
German (8) 8
Japanese (8) 8
Russian (6) 6
Spanish (2) 2
Chinese (1) 1
Hungarian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 1, pp. 51 - 69.e14
Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose of these consensus statements is to provide a review of the... 
Gastroenterology and Hepatology | Resistance | Rifabutin | Levofloxacin | Clarithromycin | Helicobacter pylori | Proton Pump Inhibitor | Amoxicillin | Bismuth | Metronidazole | Eradication | Tetracycline | CONTAINING QUADRUPLE THERAPY | CONTAINING TRIPLE-THERAPY | CONCOMITANT THERAPY | ANTIBIOTIC-RESISTANCE | SEQUENTIAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-PRACTICE GUIDELINES | STANDARD TRIPLE | LEVOFLOXACIN-CONTAINING TRIPLE | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - standards | Bismuth - administration & dosage | Drug Administration Schedule | Humans | Metronidazole - administration & dosage | Clarithromycin - standards | Proton Pump Inhibitors - standards | Amoxicillin - standards | Anti-Infective Agents - standards | Metronidazole - standards | Canada | Anti-Infective Agents - administration & dosage | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Levofloxacin - standards | Clarithromycin - administration & dosage | Adult | Amoxicillin - administration & dosage | Tetracycline - standards | Tetracycline - administration & dosage | Drug Therapy, Combination - standards | Levofloxacin - administration & dosage | Care and treatment | Continuing medical education | Surgical clinics | Children's hospitals | Helicobacter infections | Adults | Epidemiology | Antiulcer drugs
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 2/2015, Volume 60, Issue 2, pp. 458 - 464
Helicobacter pylori eradication is a challenge in penicillin allergy.To assess the efficacy and safety of first-line and rescue treatments in patients allergic... 
Biochemistry, general | Levofloxacin | Allergy | Quinolone | Oncology | Eradication | Allergic | Transplant Surgery | Medicine & Public Health | Helicobacter pylori | Hepatology | Gastroenterology | Penicillin | Bismuth | CLARITHROMYCIN | ANTIBIOTIC-RESISTANCE | QUADRUPLE THERAPY | PROTON PUMP INHIBITOR | TRIPLE THERAPY | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Predictive Value of Tests | Bismuth - administration & dosage | Prospective Studies | Humans | Middle Aged | Salvage Therapy | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Antacids - adverse effects | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Penicillins - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Levofloxacin - administration & dosage | Drug Hypersensitivity - etiology | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Breath Tests | Treatment Outcome | Spain | Medication Adherence | Helicobacter pylori - isolation & purification | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Urea | Antibacterial agents | Allergic reaction
Journal Article
Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 7, pp. 2313 - 2319
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2008, Volume 27, Issue 4, pp. 346 - 354
Summary Background  Several ‘rescue’ therapies have been recommended to eradicate Helicobacter pylori, but they still fail in >20% of the cases, and these... 
UNITED-STATES | DUODENAL-ULCER | PROTON PUMP INHIBITOR | VS. QUADRUPLE THERAPY | 2ND-LINE TREATMENT | ANTIBIOTIC-RESISTANCE | RANITIDINE BISMUTH CITRATE | TRIPLE THERAPY | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-PRACTICE | Prospective Studies | Humans | Middle Aged | Helicobacter pylori - drug effects | Rifabutin - administration & dosage | Antacids - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Treatment Failure | Organometallic Compounds - therapeutic use | Amoxicillin - administration & dosage | Drug Therapy, Combination | Ranitidine - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Anti-Infective Agents - therapeutic use | Anti-Ulcer Agents - administration & dosage | Anti-Infective Agents - administration & dosage | Amoxicillin - therapeutic use | Rifabutin - therapeutic use | Helicobacter pylori - isolation & purification | Ranitidine - administration & dosage | Antacids - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Organometallic Compounds - administration & dosage | Medicine, Experimental | Medical research | Helicobacter pylori | Analysis
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2013, Volume 62, Issue 1, pp. 21 - 27
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2006, Volume 23, Issue 4, pp. 481 - 488
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2012, Volume 186, Issue 8, pp. 797 - 802
Journal Article
13.